Toyobo Co., Ltd.

3101.T
Specialty Chemicals
2026/04/06 Updated
Market Cap: $776.8M (¥123.9B)
Stock Price: $8.80 (¥1,404)
Exchange Rate: 1 USD = ¥159.49

Regarding the Formulation of the “2030 Medium-Term Management Plan (Fiscal 2026 to 2030)”

Toyobo Co., Ltd. has formulated a medium-term management plan for fiscal 2026 to 2030, aiming to achieve an ROE exceeding 8% by fiscal 2030 and expand the ratio of core businesses from 27% to over 50%.

Importance:
Page Updated: April 6, 2026
IR Disclosure Date: April 6, 2026

Key Figures

  • ROE Target: Fiscal 2030 >8%
  • Core Business Ratio: Fiscal 2025 Outlook 27% → Fiscal 2028 >50%
  • Operating Income Plan: Fiscal 2024 ¥16.7 billion → Fiscal 2030 ¥45.0 billion

AI要約

Overview of the 2030 Medium-Term Management Plan

Toyobo Co., Ltd. has formulated a medium-term management plan for fiscal 2026 to 2030, aiming to exceed an ROE of 8% and an ROIC of 6% by fiscal 2030. The plan is based fundamentally on "thorough safety, disaster prevention, quality, and compliance" and promotes three initiatives: "business portfolio reform," "laying groundwork for the future," and "foundation building and strengthening." The ratio of core businesses is planned to expand from the fiscal 2025 outlook of 27% to over 50% by fiscal 2028, with active growth investments planned.

Financial Targets and Investment Plan

Net sales are targeted to increase from ¥422.0 billion in fiscal 2024 to ¥500.0 billion by fiscal 2030, and operating income is expected to grow from ¥16.7 billion to ¥45.0 billion. Capital expenditure will be streamlined from an average of ¥44.0 billion annually to ¥35.0 billion annually, emphasizing growth investments. Operating cash flow is planned to increase from an average of ¥22.5 billion annually in fiscal 2022-25 to ¥46.7 billion in fiscal 2026-28. Dividends will be based on stable continuation with a consolidated payout ratio target of 30%.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.